Company
Finch Therapeutics
Finch has a portfolio of innovative microbiome assets
Also known as Finch Therapeutics Group, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Boston, MA, United States
- Founded
- 2014
- Legal name
- Finch Therapeutics Group, Inc.
- finchtherapeutics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Finch, an early pioneer in the microbiome field, has established a portfolio of innovative microbiome assets with potential applicability to a wide range of product strategies and therapeutic areas.
Funding snapshot
- Total raised
- $180MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $90M2020-09-02
Funding rounds
- Round, 2020
- $90M2020-09-02, SEC form D sold, 43 investors
- Round, 2019
- $53.5M2019-05-10, SEC form D sold, 22 investors
- Round, 2018
- $36.4M2018-02-20, SEC form D sold, 14 investors
Loading relationship preview